Narayana Hrudayalaya Ltd

Narayana Hrudaya Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Narayana Hrudayalaya Ltd

₹ 1,238 -3.05%
18 Apr - close price
narayanahealth.org BSE: 539551 NSE : NH
About

Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

Key Points

Business
Company provides healthcare services and operates a chain of multi specialty, tertiary, and primary healthcare facilities. As of Q3 FY24, it has a network of 18 hospitals and 3 heart centers across India along with overseas presence at Cayman Islands, with ~5,640 operational beds and a capacity of ~6,040 beds[1]

Website BSE NSE
  • Market Cap ₹ 25,310 Cr.
  • Current Price ₹ 1,238
  • High / Low ₹ 1,445 / 749
  • Stock P/E 32.8
  • Book Value ₹ 122
  • Dividend Yield 0.20 %
  • ROCE 31.6 %
  • ROE 33.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 63.3% CAGR over last 5 years
  • Company's median sales growth is 21.4% of last 10 years

Cons

  • Stock is trading at 10.1 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
750 838 860 940 960 941 1,033 1,142 1,128 1,222 1,233 1,305 1,204
648 698 728 774 787 768 842 898 874 946 963 997 925
Operating Profit 102 140 132 167 173 172 192 244 254 276 271 308 279
OPM % 14% 17% 15% 18% 18% 18% 19% 21% 23% 23% 22% 24% 23%
5 8 7 12 7 10 8 31 12 15 15 18 18
Interest 19 18 17 17 16 16 15 15 19 21 21 23 25
Depreciation 46 44 45 46 46 47 47 49 57 56 59 55 63
Profit before tax 42 85 77 116 117 119 137 211 190 214 206 248 209
Tax % 2% 20% 1% 14% 17% 42% 19% 20% 19% 19% 11% 9% 10%
41 68 76 99 98 69 111 169 154 173 184 227 188
EPS in Rs 2.00 3.33 3.73 4.86 4.77 3.37 5.41 8.26 7.52 8.47 9.00 11.09 9.20
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
658 839 1,095 1,364 1,614 1,878 2,281 2,861 3,128 2,583 3,701 4,525 4,964
574 769 989 1,236 1,434 1,642 2,064 2,566 2,694 2,394 3,038 3,538 3,830
Operating Profit 84 70 106 128 180 236 217 295 434 189 664 987 1,133
OPM % 13% 8% 10% 9% 11% 13% 10% 10% 14% 7% 18% 22% 23%
3 28 39 6 -19 7 18 16 7 21 26 59 66
Interest 11 19 31 45 33 28 55 81 94 82 76 84 89
Depreciation 37 46 57 68 76 80 100 137 186 184 183 210 234
Profit before tax 39 34 57 21 51 135 80 93 161 -56 430 752 876
Tax % 33% 29% 38% 71% 59% 39% 36% 37% 26% 75% 20% 19%
26 24 29 -19 21 83 51 59 119 -14 342 607 772
EPS in Rs 791.33 762.14 974.49 -0.84 1.04 4.06 2.51 2.90 5.82 -0.70 16.73 29.67 37.76
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 35% 17% 0% 6% 8%
Compounded Sales Growth
10 Years: 18%
5 Years: 15%
3 Years: 13%
TTM: 17%
Compounded Profit Growth
10 Years: 49%
5 Years: 63%
3 Years: 67%
TTM: 54%
Stock Price CAGR
10 Years: %
5 Years: 42%
3 Years: 47%
1 Year: 64%
Return on Equity
10 Years: 12%
5 Years: 18%
3 Years: 22%
Last Year: 33%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0 0 0 200 204 204 204 204 204 204 204 204 204
Reserves 515 547 580 568 672 759 831 877 932 916 1,284 1,927 2,297
141 256 333 362 258 217 802 813 952 826 723 884 1,072
126 160 242 241 424 468 692 746 813 833 931 1,155 1,213
Total Liabilities 783 963 1,156 1,371 1,557 1,648 2,529 2,640 2,901 2,779 3,143 4,170 4,787
491 620 738 913 1,054 1,082 1,848 1,838 2,092 1,961 1,980 2,336 2,461
CWIP 87 44 20 20 14 53 35 56 12 20 67 259 365
Investments 0 7 51 52 87 96 9 17 86 120 132 252 526
205 292 346 385 402 417 637 729 711 678 964 1,323 1,435
Total Assets 783 963 1,156 1,371 1,557 1,648 2,529 2,640 2,901 2,779 3,143 4,170 4,787

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
53 45 110 77 174 219 182 279 443 304 485 1,085
-92 -147 -168 -223 -150 -146 -520 -162 -189 -113 -267 -1,176
38 108 57 140 18 -45 315 -27 -247 -194 -159 88
Net Cash Flow -0 6 -1 -6 42 28 -22 89 7 -2 59 -4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 37 40 45 38 34 30 45 34 31 39 43 35
Inventory Days 52 60 64 56 48 45 56 48 35 32 30 31
Days Payable 131 121 198 146 152 173 200 177 177 221 180 224
Cash Conversion Cycle -41 -21 -90 -51 -70 -98 -100 -95 -111 -150 -108 -158
Working Capital Days 5 10 2 -3 -2 -9 -4 -8 -17 -17 -0 -11
ROCE % 8% 5% 8% 7% 9% 14% 9% 9% 14% 2% 25% 32%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85%
10.96% 10.12% 10.74% 10.80% 10.64% 10.03% 9.55% 10.24% 10.36% 11.10% 11.59% 11.51%
19.59% 20.05% 19.63% 18.96% 18.34% 17.85% 16.62% 14.58% 14.14% 11.95% 10.89% 10.23%
4.89% 5.27% 5.08% 5.69% 6.47% 7.59% 9.28% 10.70% 11.01% 12.45% 13.05% 13.78%
0.71% 0.71% 0.70% 0.70% 0.70% 0.69% 0.69% 0.63% 0.63% 0.63% 0.62% 0.62%
No. of Shareholders 36,36044,52643,56543,80752,74765,17368,13073,15775,37086,6311,02,9941,20,506

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls